Crescendo

Biotechnology company developing antibody-based cancer immunotherapies and targeted biologic treatments

placeCambridge, England, United Kingdom calendar_todayFounded 2009 groups43 employees language crescendobiologics.com

Registered entities

Investor mix

25 investors on record; lead investors include Sofinnova Partners, Andera Partners, Takeda, Kreos Capital.

Investor typeCountShare
Venture capital1144%
Private equity312%
Accelerator & incubator14%
Bank & private debt28%
Other / undisclosed832%
Coming soon